iBio (IBIO) Short term Debt (2023 - 2025)
iBio's (IBIO) quarterly Short term Debt came in at $16000.0 in Q3 2025, down 91.21% year-on-year from $182000.0 in Q3 2024, and down 75.0% on a QoQ basis from $64000.0 in Q2 2025.
iBio (IBIO) Short term Debt (2023 - 2025) Analysis & Trends
iBio (IBIO) has 3 years of Short term Debt data on file, last reported at $16000.0 in Q3 2025.
- On a quarterly basis, Short term Debt fell 91.21% year-over-year to $16000.0 in Q3 2025; TTM through Sep 2025 was $16000.0, a 91.21% decrease from a year earlier, with the FY2025 full-year figure at $64000.0, down 64.04% from the prior year.
- Short term Debt for Q3 2025 stood at $16000.0, down from $64000.0 in the prior quarter.
- Over the last five years, Short term Debt for IBIO reached as high as $182000.0 in Q3 2024 and fell as low as $16000.0 in Q3 2025.
- Historically, Short term Debt has averaged $123571.4 across 3 years, with a median of $155000.0 in 2024.
- Across the five-year window, Short term Debt increased 11.25% in 2024 and slumped 91.21% in 2025, its largest moves.
- Year by year, Short term Debt stood at $160000.0 in 2023, then declined by 3.12% to $155000.0 in 2024, then slumped by 89.68% to $16000.0 in 2025.
- Per Business Quant data, the three most recent Short term Debt figures were $16000.0 in Q3 2025, $64000.0 in Q2 2025, and $110000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 64,000.00 |
| Mar 31, 2025 | 110,000.00 |
| Dec 31, 2024 | 155,000.00 |
| Sep 30, 2024 | 182,000.00 |
| Jun 30, 2024 | 178,000.00 |
| Jun 30, 2023 | 160,000.00 |